Blood sample study aims to unlock secrets of leukemia and other blood cancers

NCT ID NCT04841447

Recruiting now Knowledge-focused Sponsor: University of Missouri-Columbia Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects blood and bone marrow samples from 50 adults with blood cancers like leukemia. Researchers want to learn how a protein called DPP4 affects these cancers, which could lead to better treatments in the future. Participants provide samples during regular clinic visits, and no experimental drugs are given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward new, more personalized treatments for blood cancers like leukemia.
What could go wrong: This is an early-stage observational study with only 50 participants, so findings may not apply to all patients. It is designed to gather information, not to test a treatment directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGICAL MALIGNANCY

Contacts and locations

Locations

University of Missouri
RECRUITING

Columbia, Missouri, 65212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.